相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans
Caroline A. Arout et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
Marko Kumric et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension
Marko Kumric et al.
BIOMOLECULES (2022)
Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective
Josko Bozic et al.
BIOMEDICINES (2021)
The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey
Guido Grassi
AMERICAN JOURNAL OF HYPERTENSION (2021)
The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
Salahaden R. Sultan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Marta Baranowska-Kuczko et al.
JOURNAL OF HYPERTENSION (2020)
Renal Denervation for Resistant Hypertension: Where Do We Stand?
Bo Liang et al.
CURRENT HYPERTENSION REPORTS (2020)
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension
Jinming Fu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health
Elnaz Karimian Azari et al.
JOURNAL OF DIETARY SUPPLEMENTS (2020)
Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study
Alexander Patrician et al.
ADVANCES IN THERAPY (2019)
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek et al.
LIFE SCIENCES (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D
Emma Leishman et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Mohammad H. Forouzanfar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
Salahaden R. Sultan et al.
FRONTIERS IN PHARMACOLOGY (2017)
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
Christopher P. Stanley et al.
CARDIOVASCULAR RESEARCH (2015)
Carotid baroreflex activation therapy for resistant hypertension
Ronald G. Victor
NATURE REVIEWS CARDIOLOGY (2015)
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Torsten Lowin et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex
Alessandra M. Cathel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure Results From SYMPLICITY HTN-3
George L. Bakris et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Is the cardiovascular system a therapeutic target for cannabidiol?
Christopher P. Stanley et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Alline C. Campos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
Barbara Malinowska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Novel Peptide Isomer Strategy for Stable Inhibition of Catecholamine Release Application to Hypertension
Nilima Biswas et al.
HYPERTENSION (2012)
Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension
Lei Meng et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2011)
Presynaptic CB1 Receptors Regulate Synaptic Plasticity at Cerebellar Parallel Fiber Synapses
Megan R. Carey et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
Susanne A. Wolf et al.
CELL COMMUNICATION AND SIGNALING (2010)
Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans In Vivo
Maple M. Fung et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2010)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog
NR Mahapatra et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension
DT O'Connor et al.
JOURNAL OF HYPERTENSION (2002)
ABC of hypertension - The pathophysiology of hypertension
G Beevers et al.
BRITISH MEDICAL JOURNAL (2001)
分享论文
